GlassScriptPhysician profile
Jon Stanford
NPI 1336193200
$859.03
in general payments reported to CMS, 2019-2025
9 companies · $99.91 in 2025
The $99.91 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.28 · 2020: $47.89 · 2021: $35.07 · 2022: $63.67 · 2023: $112 · 2024: $469 · 2025: $99.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498 · Travel and Lodging: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.62 |
| Travel and Lodging | $183.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $525.90 | 2020-2025 | Da Vinci Surgical System |
| Solventum Corporation | $110.52 | 2024 | Prevena |
| Boston Scientific Corporation | $63.96 | 2025 | Farapulse |
| Ethicon US, LLC | $41.68 | 2021-2024 | Surgicel Nu-Knit |
| Medtronic Vascular, INC. | $36.51 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $25.27 | 2024 | |
| Kerecis Limited | $24.23 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Pacira Pharmaceuticals Incorporated | $17.65 | 2025 | Exparel |
| Medtronic USA, INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Stanford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.